Literature DB >> 9816283

Poly(ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer.

I Bièche1, G de Murcia, R Lidereau.   

Abstract

The poly(ADP-ribose) polymerase gene is involved in DNA repair, cell proliferation, differentiation, and malignant transformation. Because dysregulation of PARP expression might lead to genetic instability in human tumors, we examined PARP gene expression and genetic instability in 35 primary human breast carcinomas. Genetic instability was studied by analyzing nine genetic abnormalities among those most frequently observed in breast tumor DNA, including amplification of proto-oncogenes MYC and ERBB2 and chromosome regions 7p, 11q13, and 20q13, and loss of heterozygosity on chromosome arms 1p, 3p, 7p, 7q, and 11p. We found a significant link between strong PARP gene overexpression and low genetic instability (chi2corr. = 5.33; P = 0.012), pointing to a possible involvement of this gene in DNA repair in human breast tumor cells. A trend toward a link between PARP gene overexpression and amplification at 1q41-q44 (the site of the PARP gene) was also observed, suggesting that dysregulation of PARP expression could be due partly to a gene dosage effect.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9816283

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  38 in total

1.  Association between PARP-1 V762A polymorphism and cancer susceptibility: a meta-analysis.

Authors:  Hongping Yu; Hongxia Ma; Ming Yin; Qingyi Wei
Journal:  Genet Epidemiol       Date:  2011-11-29       Impact factor: 2.135

2.  The ups and downs of DNA repair biomarkers for PARP inhibitor therapies.

Authors:  Xiaozhe Wang; David T Weaver
Journal:  Am J Cancer Res       Date:  2010-01-03       Impact factor: 6.166

Review 3.  Two DNA repair gene polymorphisms on the risk of gastrointestinal cancers: a meta-analysis.

Authors:  Yue Hu; Min Zhou; Kang Li; Kai Zhang; Xiangquan Kong; Yamei Zheng; Jianxu Li; Li Liu
Journal:  Tumour Biol       Date:  2013-11-08

4.  Biomarker-Based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models.

Authors:  Susanne Kossatz; Brandon Carney; Melanie Schweitzer; Giuseppe Carlucci; Vesselin Z Miloushev; Uday B Maachani; Prajwal Rajappa; Kayvan R Keshari; David Pisapia; Wolfgang A Weber; Mark M Souweidane; Thomas Reiner
Journal:  Cancer Res       Date:  2017-01-20       Impact factor: 12.701

5.  Expression of PARP-1 and its active polymer PAR in prostate cancer and benign prostatic hyperplasia in Chinese patients.

Authors:  Wenqi Wu; Hanliang Zhu; Yeping Liang; Zhenzhen Kong; Xiaolu Duan; Shujue Li; Zhijian Zhao; Dong Yang; Guohua Zeng
Journal:  Int Urol Nephrol       Date:  2014-01-17       Impact factor: 2.370

6.  Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies.

Authors:  Leonard J Appleman; Jan H Beumer; Yixing Jiang; Yan Lin; Fei Ding; Shannon Puhalla; Leigh Swartz; Taofeek K Owonikoko; R Donald Harvey; Ronald Stoller; Daniel P Petro; Hussein A Tawbi; Athanassios Argiris; Sandra Strychor; Marie Pouquet; Brian Kiesel; Alice P Chen; David Gandara; Chandra P Belani; Edward Chu; Suresh S Ramalingam
Journal:  Cancer Chemother Pharmacol       Date:  2019-09-23       Impact factor: 3.333

7.  Non-invasive PET Imaging of PARP1 Expression in Glioblastoma Models.

Authors:  Brandon Carney; Giuseppe Carlucci; Beatriz Salinas; Valentina Di Gialleonardo; Susanne Kossatz; Axel Vansteene; Valerie A Longo; Alexander Bolaender; Gabriela Chiosis; Kayvan R Keshari; Wolfgang A Weber; Thomas Reiner
Journal:  Mol Imaging Biol       Date:  2016-06       Impact factor: 3.488

8.  PARP-1 Val762Ala polymorphism is associated with reduced risk of non-Hodgkin lymphoma in Korean males.

Authors:  Xue Mei Jin; Hee Nam Kim; Il-Kwon Lee; Kyeong-Soo Park; Hyeoung-Joon Kim; Jin-Su Choi; Sang Woo Juhng; Chan Choi
Journal:  BMC Med Genet       Date:  2010-03-03       Impact factor: 2.103

Review 9.  Targeting poly(ADP-ribose) polymerase activity for cancer therapy.

Authors:  Frédérique Mégnin-Chanet; Marc A Bollet; Janet Hall
Journal:  Cell Mol Life Sci       Date:  2010-08-20       Impact factor: 9.261

10.  PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2?

Authors:  Kristine M Frizzell; W Lee Kraus
Journal:  Breast Cancer Res       Date:  2009-11-26       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.